McCulloch Kevininsider trades
In SEC Form 4 filings, McCulloch Kevin is listed as See Remarks of Xeris Biopharma Holdings, Inc. (XERS). In the last 90 days, McCulloch Kevin sold $518.4K of Xeris Biopharma Holdings, Inc. (XERS) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| XERSXeris Biopharma Holdings, Inc. | See Remarks | 4 | Oct 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-21
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| XERSXeris Biopharma Holdings, Inc. | Oct 1 | Oct 2 | S | 15,000 | $9.41 | Sale −$141,120 | 1,599,208 | Yes | Form 4 |
| XERSXeris Biopharma Holdings, Inc. | Sep 28 | Sep 29 | S | 25,000 | $10.00 | Sale −$250,000 | 1,614,208 | Yes | Form 4 |
| XERSXeris Biopharma Holdings, Inc. | Sep 1 | Sep 1 | S | 15,000 | $8.49 | Sale −$127,308 | 1,639,208 | Yes | Form 4 |
| XERSXeris Biopharma Holdings, Inc. | Aug 1 | Aug 21 | F | 21,918 | $8.08 | $177,097 | 1,654,208 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.